טוען...
Sustainable therapies by engineered bacteria
The controlled in situ delivery of biologics (e.g. enzymes, cytokines, antibodies) by engineered bacteria of our microbiome will allow the sustainable production of these complex and expensive drugs locally in the human body, overcoming many of the technical and economical barriers currently associa...
שמור ב:
| הוצא לאור ב: | Microb Biotechnol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5609241/ https://ncbi.nlm.nih.gov/pubmed/28696008 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1751-7915.12778 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|